A gene-edited mouse with two male parents has survived to adulthood, pushing new progress on stem cell research.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...

In a groundbreaking study, scientists from China have successfully created mice with two biological fathers. Though the ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Cancer still eludes treatment, and tumors frequently evolve resistance mechanisms to get around medications. By making cancer ...

In a milestone in mammalian genetic engineering, a team of researchers from the Chinese Academy of Sciences succeeded in ...

Researchers use CRISPR to overcome seemingly insurmontable reproductive barriers — but that doesn't mean this could work for humans.

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...